# Amphastar Pharmaceuticals, Inc. (AMPH)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/AMPH/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 355.07M | $ 36.77M | $ 81.07M | $ 688.32M | $ 768.16M |
| 2025 | $ 737.10M | $ 100.44M | $ 124.13M | $ 656.00M | $ 788.81M |
| 2024 | $ 766.84M | $ 167.67M | $ 181.15M | $ 650.55M | $ 732.30M |
| 2023 | $ 696.75M | $ 148.72M | $ 157.15M | $ 623.64M | $ 639.42M |
| 2022 | $ 557.42M | $ 102.09M | $ 72.78M | $ 102.58M | $ 528.66M |
| 2021 | $ 520.35M | $ 73.83M | $ 83.85M | $ 104.66M | $ 445.52M |
| 2020 | $ 445.68M | $ 1.79M | $ 29.82M | $ 67.27M | $ 402.31M |
| 2019 | $ 416.08M | $ 63.17M | $ 267.2K | $ 66.63M | $ 381.37M |
| 2018 | $ 389.16M | $ -7.63M | $ -11.38M | $ 50.21M | $ 332.44M |
| 2017 | $ 323.55M | $ 6.07M | $ 5.54M | $ 47.16M | $ 337.33M |
| 2016 | $ 351.06M | $ 14.49M | $ 23.63M | $ 37.72M | $ 329.26M |
| 2015 | $ 353.14M | $ -3.91M | $ -7.53M | $ 41.10M | $ 295.51M |
| 2014 | $ 297.38M | $ -15.12M | $ 781.4K | $ 43.70M | $ 281.86M |
| 2013 | $ 326.66M | $ 16.87M | $ 18.12M | $ 32.17M | $ 251.55M |
| 2012 | $ 75.15M | $ 6.30M | $ -2.18M | $ 0 | $ 233.44M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.90 |
| Liabilities / Eq | 1.27 |
| Current Ratio | 2.40 |

## Debt coverage

| Indicator | Value |
| --- | --- |
| Gross Debt / Earnings | 9.91 |
| Gross Debt / FCF | 9.44 |

## Other views

- [Metrics](https://sponda.capital/en/AMPH.md)
- [Charts](https://sponda.capital/en/AMPH/charts.md)
- [Compare](https://sponda.capital/en/AMPH/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.